Medical Devices Startups

CAIRE develops and manufactures oxygen delivery equipment and services for medical and commercial applications, including products under its AirSep, HELiOS, and SeQual brands. Its customers include hospitals and military personnel who rely on high-performance oxygen delivery products.

1 investor

Cajal Therapeutics develops novel therapies through translating scientific advances into treatments for patients. The company is led by a team of experienced scientists and operators focused on drug discovery and development.

1 investor

Calder Biosciences develops protein-based subunit vaccines using its 3D-Vaxlock technology, which uses dityrosine crosslinking to lock immunogens into the shape they hold on a virus surface for improved antibody responses. Its engineered immunogens aim to offer better safety, efficacy, thermostability, and reduced cold chain requirements against infectious diseases.

1 investor

Calgary Scientific develops a mobile visualization platform for healthcare professionals that enables secure access to 2D/3D medical images for collaboration and diagnosis across any device without duplicating source files.

1 investor

Calla Lily Clinical Care is a women's health company developing intravaginal drug delivery products based on its proprietary Callavid platform device, targeting IVF, prevention of preterm birth and miscarriage, delivery of live biotherapeutics to restore the vaginal microbiome, and biomarker sample collection for diagnostics such as endometriosis. Its FDA-cleared device technology serves the women's health and medical device market.

1 investor

Calosense provides a comprehensive weight loss platform offering clinical guidance and remote patient monitoring for GLP-1 therapy management.

1 investor

Calyxo develops medical devices for kidney stone removal, specifically a minimally invasive CVAC (Cavitation-Enabled Ablation and Clearance) system that has been FDA-cleared. The company serves urologists and patients seeking routine, single-treatment kidney stone management.

1 investor

Cambridge Nucleomics develops a single-molecule RNA counting "nanoarray" assay based on solid-state nanopore and DNA nanotechnology for diagnostic testing. The company applies its technology to RNA biology and microbiology-based diagnostics.

1 investor

Cambridge Orthopaedic Labs develops non-invasive trauma fixation technologies for orthopaedic trauma surgery, including a platform for non-surgical management of fractures used by surgeons and healthcare providers. The company conducts research in Cambridge, UK and runs headquarters and sales operations in Pennsylvania, US.

1 investor

Cambridge Vision Technology develops diagnostic hardware and software for detecting Alzheimer's disease and other neurodegenerative conditions through retinal imaging and biomarker analysis. The company serves healthcare providers seeking early, non-invasive screening tools for preclinical Alzheimer's disease risk.

1 investor

Cambus Medical (part of Freudenberg Medical) manufactures metal hypotubes, precision small-diameter metal tubing, steerable catheter components, specialty needles, and pull-wire assemblies for minimally invasive medical devices. It serves medical device OEMs building cardiovascular, neurovascular, endoscopy, electrophysiology, and structural heart devices, and also provides proprietary coatings and value-added manufacturing.</parameter> <parameter name="founders">[]

1 investor

Canada Diagnostic Centres operates diagnostic imaging clinics across Alberta, providing radiological and medical imaging services to patients referred by healthcare practitioners. The company serves patients and referring physicians through 20 clinic locations staffed by radiologists and clinicians.

1 investor

Canadian Dental Labs operates dental laboratory services with multiple brand divisions and regional operations across Canada.

1 investor

Canary Medical develops implantable orthopedic medical devices, including smart sensors and digital health solutions, for knee replacement and other surgical applications. The company serves orthopedic surgeons and patients undergoing joint arthroplasty procedures.

1 investor

Canary Health Tech partners with scientists, doctors, engineers, and health providers to develop health technology solutions. The company collaborates with established health systems and engineering partners to advance healthcare innovation.

1 investor

Cancer Free provides personalized cancer drug testing services using blood samples to create in vitro tumor models (avatar medicine) that allow physicians to test multiple drug combinations before patient treatment. The platform serves oncologists and cancer patients across multiple drug categories including chemotherapy, hormone therapy, and targeted therapy.

1 investor

Emergent is a public health company that develops and manufactures medical countermeasures and protective solutions for endemic public health threats, national security preparedness, and supports biopharma innovators and organizations with manufacturing.

1 investor

Cannaray Limited operates two business divisions: Cannaray CBD, a wellness brand offering CBD oils, capsules, gummies, and topicals for consumer use; and Therismos, a medical cannabis division that imports and distributes cannabis-based pharmaceutical products across Europe. The company serves both retail consumers seeking CBD wellness products and medical practitioners supporting patients in the cannabis therapeutics market.

1 investor

Cannuflow designs and manufactures proprietary surgical fluid management devices for arthroscopic procedures on the knee, shoulder, hip, and ankle. The company's products address chronic surgical challenges including cartilage injury, fluid visualization, extravasation, and portal access for orthopedic surgeons.

1 investor

CanSino Biologics develops and manufactures vaccines, including tetanus, whooping cough, pneumococcal, meningococcal, and COVID-19 vaccines for prevention of infectious diseases. The company serves healthcare systems and immunization programs, primarily in China and Asia.

1 investor

Cantourage imports and distributes medical cannabis sourced from cultivators worldwide to patients, pharmacies, and healthcare providers in Germany and across Europe. The company also develops cannabis-related pharmaceutical products and operates a platform connecting international growers with the European medical cannabis market.

1 investor

Capcyte Biotherapeutics develops surface modification technology for cardiovascular implants to improve hemocompatibility, with applications in therapeutic cell culture and other medical fields.

1 investor

Capitan Orthopedics develops SupraSpacer, a minimally invasive shoulder implant that acts as a spacer to restore joint alignment for patients with irreparable rotator cuff tears. The device targets surgeons and outpatient surgical centers as an alternative for patients who are not candidates for traditional tendon repair or reverse shoulder replacement.

1 investor

Capricor Therapeutics is a biotechnology company developing allogeneic cardiosphere-derived cell (CDC) and exosome-based therapeutics to treat serious diseases including Duchenne muscular dystrophy. The company uses cell and exosome biology platforms to create novel therapeutic medicines for patient treatment.

1 investor